CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: A genome-wide linkage and sequencing study

The Lancet Neurology

Volumn 14, Issue 3, 2015, Pages 274-282

  Funayama, Manabu ^a,e   Ohe, Kenji ^b,c   Amo, Taku ^d   Furuya, Norihiko ^a,e   Yamaguchi, Junji ^e   Saiki, Shinji ^e   Li, Yuanzhe ^e   Ogaki, Kotaro ^e   Ando, Maya ^e   Yoshino, Hiroyo ^a   Tomiyama, Hiroyuki ^e   Nishioka, Kenya ^e   Hasegawa, Kazuko ^f   Saiki, Hidemoto ^g   Satake, Wataru ^h   Mogushi, Kaoru ^e   Sasaki, Ryogen ⁱ   Kokubo, Yasumasa ^j   Kuzuhara, Shigeki ^k   Toda, Tatsushi ^h   Mizuno, Yoshikuni ^e   Uchiyama, Yasuo ^a,e   Ohno, Kinji ^b   Hattori, Nobutaka ^a,e   more..

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NATIONAL DEFENSE ACADEMY   (Japan)

^e JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^g Kitano Hospital   (Japan)

^h KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j MIE UNIVERSITY   (Japan)

^k SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COILED COIL HELIX COILED COIL HELIX DOMAIN CONTAINING 2 PROTEIN; UNCLASSIFIED DRUG; CHCHD2 PROTEIN, HUMAN; MITOCHONDRIAL PROTEIN; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; COMPREHENSION; CONTROLLED STUDY; FEMALE; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; HUMAN; JAPANESE (PEOPLE); LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEXT GENERATION SEQUENCING; PARKINSON DISEASE; PRIORITY JOURNAL; AGED; DNA SEQUENCE; GENETICS; MIDDLE AGED; MISSENSE MUTATION; ONSET AGE; PARKINSONIAN DISORDERS; PEDIGREE; PROCEDURES; TUMOR CELL LINE; VERY ELDERLY;

AGE OF ONSET; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; FEMALE; GENETIC LINKAGE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; MUTATION, MISSENSE; PARKINSONIAN DISORDERS; PEDIGREE; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTORS;

EID: 84923226964     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(14)70266-2     Document Type: Article

References (32)

1. Shino MY, McGuire V, Van Den Eeden SK, et al. Familial aggregation of Parkinson's disease in a multiethnic community-based case-control study. Mov Disord 2010, 25:2587-2594.
2. Singleton AB, Farrer MJ, Bonifati V The genetics of Parkinson's disease: progress and therapeutic implications. Mov Disord 2013, 28:14-23.
3. Lautier C, Goldwurm S, Dürr A, et al. Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease. Am J Hum Genet 2008, 82:822-833.
4. Vilariño-Güell C, Rajput A, Milnerwood AJ, et al. DNAJC13 mutations in Parkinson disease. Hum Mol Genet 2014, 23:1794-1801.
5. Schapira AH, Olanow CW, Greenamyre JT, Bezard E Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives. Lancet 2014, 384:545-555.
6. Hughes AJ, Daniel SE, Kilford L, Lees AJ Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992, 55:181-184.
7. Fukuda Y, Nakahara Y, Date H, et al. SNP HiTLink: a high-throughput linkage analysis system employing dense SNP data. BMC Bioinformatics 2009, 10:121.
8. Abecasis GR, Cherny SS, Cookson WO, Cardon LR Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002, 30:97-101.
9. Li H, Durbin R Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009, 25:1754-1760.
10. Li H, Handsaker B, Wysoker A, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009, 25:2078-2079.
11. Saitsu H, Nishimura T, Muramatsu K, et al. De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood. Nat Genet 2013, 45:445-449.
12. Masuda A, Shen XM, Ito M, Matsuura T, Engel AG, Ohno K hnRNP H enhances skipping of a nonfunctional exon P3A in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndrome. Hum Mol Genet 2008, 17:4022-4035.
13. Ohe K, Mayeda A HMGA1a trapping of U1 snRNP at an authentic 5' splice site induces aberrant exon skipping in sporadic Alzheimer's disease. Mol Cell Biol 2010, 30:2220-2228.
14. Sham PC, Purcell SM Statistical power and significance testing in large-scale genetic studies. Nat Rev Genet 2014, 15:335-346.
15. Narahara M, Higasa K, Nakamura S, et al. Large-scale east-Asian eQTL mapping reveals novel candidate genes for LD mapping and the genomic landscape of transcriptional effects of sequence variants. PLoS One 2014, 9:e100924.
16. Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010, 7:248-249.
17. Schwarz JM, Rödelsperger C, Schuelke M, Seelow D MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods 2010, 7:575-576.
18. Kumar P, Henikoff S, Ng PC Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009, 4:1073-1081.
19. Desmet FO, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, Beroud C Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acid Res 2009, 37:e67.
20. Sahashi K, Masuda A, Matsuura T, et al. In vitro and in silico analysis reveals an efficient algorithm to predict the splicing consequences of mutations at the 5' splice sites. Nucleic Acids Res 2007, 35:5995-6003.
21. Satake W, Nakabayashi Y, Mizuta I, et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 2009, 41:1303-1307.
22. Aras S, Bai M, Lee I, Springett R, Hüttemann M, Grossman LI MNRR1 (formerly CHCHD2) is a bi-organellar regulator of mitochondrial metabolism. Mitochondrion 2015, 20:43-51.
23. Baughman JM, Nilsson R, Gohil VM, Arlow DH, Gauhar Z, Mootha VK A computational screen for regulators of oxidative phosphorylation implicates SLIRP in mitochondrial RNA homeostasis. PLoS Genet 2009, 5:e1000590.
24. Longen S, Bien M, Bihlmaier K, et al. Systematic analysis of the twin cx(9)c protein family. J Mol Biol 2009, 393:356-368.
25. Liu Y, Clegg HV, Leslie PL, et al. CHCHD2 inhibits apoptosis by interacting with Bcl-x L to regulate Bax activation. Cell Death Differ 2014, published online Dec 5. 10.1038/cdd.2014.194.
26. Fekete R, Jankovic J Revisiting the relationship between essential tremor and Parkinson's disease. Mov Disord 2011, 26:391-398.
27. Puschmann A, Pfeiffer RF, Stoessl AJ, et al. A family with parkinsonism, essential tremor, restless legs syndrome, and depression. Neurology 2011, 76:1623-1630.
28. Feyeux M, Bourgois-Rocha F, Redfern A, et al. Early transcriptional changes linked to naturally occurring Huntington's disease mutations in neural derivatives of human embryonic stem cells. Hum Mol Genet 2012, 21:3883-3895.
29. Aras S, Pak O, Sommer N, et al. Oxygen-dependent expression of cytochrome c oxidase subunit 4-2 gene expression is mediated by transcription factors RBPJ, CXXC5 and CHCHD2. Nucleic Acids Res 2013, 41:2255-2266.
30. Kondapalli C, Kazlauskaite A, Zhang N, et al. PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65. Open Biol 2012, 2:120080.
31. Koyano F, Okatsu K, Kosako H, et al. Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature 2014, 510:162-166.
32. Bragoszewski P, Gornicka A, Sztolsztener ME, Chacinska A The ubiquitin-proteasome system regulates mitochondrial intermembrane space proteins. Mol Cell Biol 2013, 33:2136-2148.